US Health Spending Set to Exceed $6 Trillion in 2026 on Prescription Drug Surge
The US is expected to spend more than $560 billion on prescription medications in 2026, up 8.2% from…
A Heart Medication Has Been Recalled Nationwide, Reports FDA
Amgen is a pharmaceutical manufacturer name you might recognize—and if you take this heart medication, it’s worth checking…
Shortages stop pharmacies dispensing medication ‘at least once a day’
The majority of pharmacies (89%) were unable to dispense a medicine at least once a day in the…
Mounjaro’s scathing rejection explains why drug access is failing – The Australian
Mounjaro’s scathing rejection explains why drug access is failing The AustralianFriday essay: I had to crowdfund my cancer treatment…
FDA recall raises concern over blood pressure drug
A prescription drug recall can be easy to miss, especially when it does not come with a major…
TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)
CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has…
People who take statins told to ‘move medication’ in urgent health alert
The UK Health Security Agency (UKHSA) has issued red heat health warnings as temperatures soar People who take…
Subscribe to The Australian | Newspaper home delivery, website, iPad, iPhone & Android apps
The Australian Digital subscription costs $24 (min. cost) charged every 4 weeks for a duration of 52 weeks,…
New Pilot Program Offers Reduced Cost GL-1 Medications | News
WHITESBORO, N.Y — Starting next Wednesday, eligible Medicare patients will be able to enroll in the new Medicare…
Recall pulls 400,000 bottles of anti-depressant over cancer risk
Thousands of bottles of an antidepressant medication have been flagged for recall because they may contain elevated levels…
Weight-loss drug approved to treat sleep apnea in Canada
Listen to this article Estimated 4 minutes The audio version of this article is generated by AI-based technology.…
Wegovy, Zepbound: $50 GLP-1 Drugs Are Coming for Medicare Recipients
Share on PinterestAn estimated 14 million Medicare Part D recipients could obtain Wegovy, Foundayo, and Zepbound for $50…